cefotiam has been researched along with arbekacin in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Nakane, Y; Oda, S; Suzuki, Y; Yokota, N | 1 |
Kanno, M; Kawabata, T; Sobu, K; Takase, Y; Watanabe, T; Yoshida, T | 1 |
Arakawa, K; Kono, K; Takeda, S; Tatara, I | 1 |
Hori, K; Ishikawa, S; Mashita, K; Mizuno, A; Shinagawa, N; Yura, J | 1 |
Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Suzuki, K; Suzuki, Y; Yokota, N | 1 |
5 other study(ies) available for cefotiam and arbekacin
Article | Year |
---|---|
[Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. III. Combined effects of arbekacin with cefotiam or cefuzonam].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefotiam; Ceftizoxime; Dibekacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Synergism; Methicillin Resistance; Staphylococcus aureus | 1992 |
[Basic studies on combination effects of arbekacin and beta-lactam antibiotics on methicillin-resistant Staphylococcus aureus].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefotiam; Cephalosporins; Cilastatin; Dibekacin; Drug Therapy, Combination; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus | 1994 |
In vitro activities of arbekacin, alone and in combination, against methicillin-resistant Staphylococcus aureus.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefotiam; Ceftizoxime; Cephalosporins; Dibekacin; Drug Therapy, Combination; Fosfomycin; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus | 1994 |
[Efficacy of arbekacin, a new aminoglycoside antibiotic, in surgical patients with MRSA infections].
Topics: Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Cefotiam; Cilastatin; Dibekacin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Methicillin Resistance; Postoperative Complications; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection | 1994 |
[Bacteriological evaluations of combination effects with cefotiam and other antimicrobial agents against methicillin-resistant Staphylococcus aureus. II. Synergistic actions of cefotiam with arbekacin and minocycline].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefotiam; Dibekacin; Drug Synergism; Drug Therapy, Combination; Methicillin Resistance; Microbial Sensitivity Tests; Minocycline; Staphylococcus aureus | 1993 |